| 000 | 01790 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517223915.0 | ||
| 264 | 0 | _c20190212 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1464-5491 | ||
| 024 | 7 |
_a10.1111/dme.13770 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLyall, M J | |
| 245 | 0 | 0 |
_aDiurnal profile of interstitial glucose following dexamethasone prophylaxis for chemotherapy treatment of gynaecological cancer. _h[electronic resource] |
| 260 |
_bDiabetic medicine : a journal of the British Diabetic Association _c11 2018 |
||
| 300 |
_a1508-1514 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 | _aBlood Glucose Self-Monitoring |
| 650 | 0 | 4 |
_aChemoprevention _xmethods |
| 650 | 0 | 4 |
_aCircadian Rhythm _xdrug effects |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 |
_aExtracellular Fluid _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenital Neoplasms, Female _xdrug therapy |
| 650 | 0 | 4 |
_aGlucose _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xchemically induced |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonitoring, Physiologic _xmethods |
| 650 | 0 | 4 |
_aSkin _xchemistry |
| 700 | 1 | _aThethy, I | |
| 700 | 1 | _aSteven, L | |
| 700 | 1 | _aMacKean, M | |
| 700 | 1 | _aNussey, F | |
| 700 | 1 | _aSakala, M | |
| 700 | 1 | _aRye, T | |
| 700 | 1 | _aStrachan, M W J | |
| 700 | 1 | _aDover, A R | |
| 773 | 0 |
_tDiabetic medicine : a journal of the British Diabetic Association _gvol. 35 _gno. 11 _gp. 1508-1514 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/dme.13770 _zAvailable from publisher's website |
| 999 |
_c28565874 _d28565874 |
||